{"nct_id":"NCT06635824","title":"Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2024-11-25","start_date_type":"ACTUAL","primary_completion_date":"2027-01-31","primary_completion_date_type":"ESTIMATED","completion_date":"2029-10-31","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GMAB"]}